Quality Indicators in Barrett’s Esophagus: Time to Change the Status Quo

다국어 초록 (Multilingual Abstract)

The push for high quality care in all fields of medicine highlights the importance of establishing and adhering to quality indicators.
In response, several gastrointestinal societies have established quality indicators specific to Barrett’s esophagus, which serve to createthresholds for performance while standardizing practice and guiding value-based care. Recent studies, however, have consistentlydemonstrated the lack of adherence to these quality indicators, particularly in surveillance (appropriate utilization of endoscopy andobtaining biopsies using the Seattle protocol) and endoscopic eradication therapy practices. These findings suggest that innovativeinterventions are needed to address these shortcomings in order to deliver high quality care to patients with Barrett’s esophagus.

참고문헌 (Reference)

1 Tavakkoli A, "Use of appropriate surveillance for patients with nondysplastic Barrett's esophagus" 16 : 862-869, 2018

2 Desai TK, "The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis" 61 : 970-976, 2012

3 Sharma P, "The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria" 131 : 1392-1399, 2006

4 Sharma P, "Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial" 62 : 15-21, 2013

5 Wani S, "Risk factors for progression of lowgrade dysplasia in patients with Barrett's esophagus" 141 : 1179-1186, 2011

6 Wani SB, "Regional variations and trends in quality indicator (QI) performance in Barrett's esophagus (BE): results from a population-based study using a national benchmarking registry" 87 (87): AB537-, 2018

7 Komanduri S, "Recurrence of Barrett's esophagus is rare following endoscopic eradication therapy coupled with effective reflux control" 112 : 556-566, 2017

8 Phoa KN, "Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and lowgrade dysplasia: a randomized clinical trial" 311 : 1209-1217, 2014

9 Shaheen NJ, "Radiofrequency ablation in Barrett's esophagus with dysplasia" 360 : 2277-2288, 2009

10 Vogt JS, "Quality of endoscopic surveillance of Barrett's esophagus" 53 : 256-259, 2018

11 Sharma P, "Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium" 149 : 1599-1606, 2015

12 Rizk MK, "Quality indicators common to all GI endoscopic procedures" 81 : 3-16, 2015

13 van Vilsteren FG, "Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study" 45 : 516-525, 2013

14 Wani SB, "Over-utilization of repeat upper endoscopy in patients with non-dysplastic Barrett's esophagus: a population-based study using a national benchmarking registry" 154 (154): S28-S29, 2018

15 Rubenstein JH, "Measuring the quality of Barrett's esophagus management with measures that are high quality" 149 : 1298-1301, 2015

16 Curvers WL, "Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated" 105 : 1523-1530, 2010

17 Pech O, "Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus" 57 : 1200-1206, 2008

18 Shaheen NJ, "Less is more: a minimalist approach to endoscopy" 154 : 1993-2003, 2018

19 Wani S, "Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett's dysplasia" 8 : 783-788, 2010

20 Han S, "Factors associated with suboptimal adherence to quality indicators in Barrett's esophagus" 154 (154): S-140, 2018

21 Wani SB, "Endoscopists biopsy the least those who need it the most: an analysis of Barrett's esophagus biopsy practices from a national quality benchmarking registry" 87 (87): AB114-, 2018

22 Moss A, "Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit" 105 : 1276-1283, 2010

23 Standards of Practice Committee, "Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer" 87 : 907-931, 2018

24 Qumseya BJ, "Disease progression in Barrett's low-grade dysplasia with radiofrequency ablation compared with surveillance: systematic review and meta-analysis" 112 : 849-865, 2017

25 Wani S, "Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium" 86 : 1-17, 2017

26 Wani S, "Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium" 112 : 1032-1048, 2017

27 Cotton CC, "Development of evidence based surveillance intervals following radiofrequency ablation of Barrett's esophagus" 2018

28 Scholvinck DW, "Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists" 49 : 113-120, 2017

29 Ooi J, "Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate" 49 : 524-528, 2017

30 Fitzgerald RC, "British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus" 63 : 7-42, 2014

31 Thrift AP, "Barrett's esophagus and esophageal adenocarcinoma: how common are they really?" 63 : 1988-1996, 2018

32 Institute of Medicine, "America's health in transition: protecting and improving quality" National Academies Press 1994

33 Qumseya BJ, "Adverse events after radiofrequency ablation in patients with Barrett's esophagus: a systematic review and meta-analysis" 14 : 1086-1095, 2016

34 Westerveld D, "Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis" 6 : E300-E307, 2018

35 Abrams JA, "Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States" 7 : 736-742, 2009